Royce & Associates’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.4M Sell
168,559
-20,755
-11% -$1.52M 0.13% 240
2025
Q1
$21.6M Sell
189,314
-148,986
-44% -$17M 0.23% 122
2024
Q4
$17M Sell
338,300
-24,972
-7% -$1.26M 0.16% 184
2024
Q3
$16.8M Buy
363,272
+13,000
+4% +$602K 0.15% 186
2024
Q2
$11.4M Buy
350,272
+14,000
+4% +$455K 0.11% 272
2024
Q1
$8.47M Buy
336,272
+197
+0.1% +$4.96K 0.08% 375
2023
Q4
$10.9M Sell
336,075
-17,029
-5% -$553K 0.1% 287
2023
Q3
$9.62M Buy
353,104
+59,363
+20% +$1.62M 0.1% 301
2023
Q2
$6.54M Sell
293,741
-12,513
-4% -$278K 0.06% 435
2023
Q1
$6.63M Buy
306,254
+46,780
+18% +$1.01M 0.07% 420
2022
Q4
$5.27M Sell
259,474
-13,239
-5% -$269K 0.06% 459
2022
Q3
$6.99M Sell
272,713
-7,737
-3% -$198K 0.08% 359
2022
Q2
$6.67M Buy
280,450
+69
+0% +$1.64K 0.07% 400
2022
Q1
$6.31M Buy
280,381
+227,477
+430% +$5.12M 0.05% 493
2021
Q4
$1.05M Buy
52,904
+3,041
+6% +$60.2K 0.01% 800
2021
Q3
$981K Sell
49,863
-2,310
-4% -$45.4K 0.01% 820
2021
Q2
$1.15M Sell
52,173
-270
-0.5% -$5.94K 0.01% 834
2021
Q1
$1.25M Sell
52,443
-8,760
-14% -$208K 0.01% 825
2020
Q4
$1.6M Sell
61,203
-1,503
-2% -$39.3K 0.01% 761
2020
Q3
$1.09M Sell
62,706
-570
-0.9% -$9.92K 0.01% 771
2020
Q2
$1.06M Sell
63,276
-2,165
-3% -$36.4K 0.01% 766
2020
Q1
$778K Sell
65,441
-1,271
-2% -$15.1K 0.01% 772
2019
Q4
$807K Buy
66,712
+6,915
+12% +$83.6K 0.01% 832
2019
Q3
$845K Buy
59,797
+20,298
+51% +$287K 0.01% 832
2019
Q2
$440K Buy
39,499
+17,093
+76% +$190K ﹤0.01% 924
2019
Q1
$263K Buy
22,406
+21,159
+1,697% +$248K ﹤0.01% 983
2018
Q4
$17K Sell
1,247
-371
-23% -$5.06K ﹤0.01% 1120
2018
Q3
$23K Buy
1,618
+871
+117% +$12.4K ﹤0.01% 1141
2018
Q2
$12K Buy
+747
New +$12K ﹤0.01% 1185